Europlasma S.A. sell nvestor
Start price
20.03.21
/
50%
€15,600
Target price
20.03.22
€0.000
Performance (%)
-3.97%
End price
03.04.21
€14,980
Summary
This prediction ended on 03.04.21 with a price of €14,980. With a performance of -3.97%, the SELL prediction for Europlasma S.A. by nvestor was down slightly. nvestor has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Europlasma S.A. | -50.000% | -50.000% | -99.940% | -100.000% |
| iShares Core DAX® | -0.992% | -3.231% | 11.661% | 16.545% |
| iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% | 43.334% |
| iShares Nikkei 225® | -0.736% | -7.859% | 18.597% | 4.253% |
| iShares S&P 500 | -0.509% | -2.979% | 26.341% | 40.911% |
According to nvestor what are the pros and cons of Europlasma S.A. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Low dividend yield expected
negative Cash Flow expected
Bad rating
Little Investments for future growth
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Below average Management
Little innovation
Bad culture
Few uniques
Dependend from some customers or products
Growths slower than the competition
high free float
Higher risks for its business
Sustainability is little important
Below average Marketposition
Significant cyclical dependencies
Little known brand
Business model of the past or high risk
Comments by nvestor for this prediction
In the thread Europlasma S.A. diskutieren
Sell mit Kursziel 0,0
In the thread Trading Europlasma S.A.
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.